IL153943A0 - SUBSTRATES AND ASSAYS FOR beta-SECRETASE ACTIVITY - Google Patents
SUBSTRATES AND ASSAYS FOR beta-SECRETASE ACTIVITYInfo
- Publication number
- IL153943A0 IL153943A0 IL15394301A IL15394301A IL153943A0 IL 153943 A0 IL153943 A0 IL 153943A0 IL 15394301 A IL15394301 A IL 15394301A IL 15394301 A IL15394301 A IL 15394301A IL 153943 A0 IL153943 A0 IL 153943A0
- Authority
- IL
- Israel
- Prior art keywords
- substrates
- assays
- beta
- secretase activity
- asp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21979500P | 2000-07-19 | 2000-07-19 | |
US27525101P | 2001-03-12 | 2001-03-12 | |
PCT/US2001/023035 WO2002006306A2 (en) | 2000-07-19 | 2001-07-19 | SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
Publications (1)
Publication Number | Publication Date |
---|---|
IL153943A0 true IL153943A0 (en) | 2003-07-31 |
Family
ID=26914256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15394301A IL153943A0 (en) | 2000-07-19 | 2001-07-19 | SUBSTRATES AND ASSAYS FOR beta-SECRETASE ACTIVITY |
Country Status (11)
Country | Link |
---|---|
US (8) | US7205120B2 (xx) |
EP (1) | EP1301604B1 (xx) |
JP (1) | JP2004504018A (xx) |
AT (1) | ATE397077T1 (xx) |
AU (1) | AU2001277950A1 (xx) |
CA (1) | CA2410898A1 (xx) |
DE (1) | DE60134230D1 (xx) |
IL (1) | IL153943A0 (xx) |
IS (1) | IS6678A (xx) |
TW (2) | TWI316960B (xx) |
WO (1) | WO2002006306A2 (xx) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1161769C (zh) | 1998-04-06 | 2004-08-11 | 伊美申公司 | 数据存储盘的反转光学母盘的制造 |
US7196163B2 (en) | 2001-05-22 | 2007-03-27 | Merk & Co., Inc. | Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
IL150601A (en) * | 2001-07-19 | 2010-06-30 | Organon Nv | Process for rapid synthesis of peptides within a solution using the back of an activated carboxyl component and destruction of the residual activated carboxyl component |
IL150600A (en) * | 2001-07-19 | 2005-09-25 | Akzo Nobel Nv | Process for the preparation of compounds containing one or more amide bonds using an excess of an activated carboxylic component and scavenging the residual activated carboxylic component |
CA2482824A1 (en) * | 2002-04-18 | 2003-10-23 | Esbatech Ag | Method for the identification of modulators of a secretase activity |
JP2004000060A (ja) * | 2002-05-31 | 2004-01-08 | Otsuka Pharmaceut Co Ltd | アミロイドβ産生に影響を与える化合物のスクリーニング方法 |
CA2505907A1 (en) * | 2002-11-14 | 2004-06-03 | Qtl Biosystems, Llc | Methods of biosensing using fluorescent polymers and quencher-tether-ligand bioconjugates |
US20050112696A1 (en) * | 2003-11-25 | 2005-05-26 | The University Of Texas Southwestern Medical Center | Compositions, methods and assays related to secretase cleavage specificity |
US20060098887A1 (en) * | 2004-05-19 | 2006-05-11 | Hazem El-Bakry | Mehthod for image conversion |
CN101142194B (zh) * | 2005-03-14 | 2012-10-10 | 顶点制药有限责任公司 | 吲哚衍生物,组合物及用作β-分泌酶抑制剂的方法 |
DE102005051978A1 (de) * | 2005-10-31 | 2007-05-10 | Forschungszentrum Borstel Zentrum für Medizin und Biowissenschaften | Verfahren zur Bestimmung der Spaltbarkeit von Substraten |
JP4848986B2 (ja) * | 2007-03-22 | 2011-12-28 | 富士ゼロックス株式会社 | 光導波路及びその製造方法 |
US8548257B2 (en) * | 2009-01-05 | 2013-10-01 | Apple Inc. | Distinguishing between faces and non-faces |
AU2011326564A1 (en) | 2010-11-10 | 2013-05-09 | Genentech, Inc. | Methods and compositions for neural disease immunotherapy |
JP2013158281A (ja) * | 2012-02-03 | 2013-08-19 | Shionogi & Co Ltd | 新規bace1活性測定方法 |
US11008403B2 (en) | 2014-11-19 | 2021-05-18 | Genentech, Inc. | Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use |
JP6859259B2 (ja) | 2014-11-19 | 2021-04-14 | ジェネンテック, インコーポレイテッド | BACElに対する抗体及び神経疾患免疫療法のためのその使用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292652A (en) | 1990-10-05 | 1994-03-08 | Athena Neurosciences, Inc. | Amyloidin protease and uses thereof |
US5798224A (en) * | 1992-12-29 | 1998-08-25 | Doheny Eye Institute | Nucleic acids encoding protocadherin |
JP4052605B2 (ja) * | 1994-05-18 | 2008-02-27 | タカラバイオ株式会社 | α−1,3/4−フコシダーゼ遺伝子 |
WO1996040885A2 (en) * | 1995-06-07 | 1996-12-19 | Athena Neurosciences, Inc. | β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
US6803188B1 (en) * | 1996-01-31 | 2004-10-12 | The Regents Of The University Of California | Tandem fluorescent protein constructs |
GB9701684D0 (en) | 1997-01-28 | 1997-03-19 | Smithkline Beecham Plc | Novel compounds |
WO1999040930A1 (en) * | 1998-02-12 | 1999-08-19 | Center For Blood Research, Inc. | Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases |
US7090976B2 (en) * | 1999-11-10 | 2006-08-15 | Rigel Pharmaceuticals, Inc. | Methods and compositions comprising Renilla GFP |
AU4045599A (en) * | 1998-06-05 | 1999-12-30 | Aventis Pharma S.A. | Polypeptides with beta-secretase type activity |
ATE276754T1 (de) * | 1998-07-21 | 2004-10-15 | Cytovia Inc | Neue fluoreszensfarbstoffe und ihre anwendung in fluoreszensnachweisverfahren ganzer zellen für kaspasen, peptidasen, proteasen und andere enzyme sowie deren verwendung |
NZ527053A (en) | 1998-09-24 | 2005-04-29 | Upjohn Co | Modified amyloid precursor protein polynucleotides and polypeptides |
US6313268B1 (en) * | 1998-10-16 | 2001-11-06 | Vivian Y. H. Hook | Secretases related to Alzheimer's dementia |
AU4000900A (en) | 1999-02-10 | 2000-08-29 | Elan Pharmaceuticals, Inc. | Beta-secretase enzyme compositions and methods |
WO2000058479A1 (en) | 1999-03-26 | 2000-10-05 | Amgen Inc. | Beta secretase genes and polypeptides |
EP1196609A2 (en) * | 1999-06-28 | 2002-04-17 | Oklahoma Medical Research Foundation | Catalytically active recombinant memapsin and methods of use thereof |
US7429639B2 (en) * | 1999-09-29 | 2008-09-30 | Ludwig Institute For Cancer Research | SSX-2 peptides presented by HLA class II molecules |
GB9925136D0 (en) * | 1999-10-22 | 1999-12-22 | Smithkline Beecham Plc | Novel treatment |
CN1414976A (zh) * | 1999-12-08 | 2003-04-30 | 明德塞特生物制药(美国)公司 | 作为免疫原的嵌合肽及其抗体,以及利用嵌合肽或抗体进行免疫的方法 |
US6737420B2 (en) * | 2000-03-23 | 2004-05-18 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
US20030096864A1 (en) * | 2000-06-30 | 2003-05-22 | Fang Lawrence Y. | Compounds to treat alzheimer's disease |
WO2002094985A2 (en) | 2001-05-22 | 2002-11-28 | Merck & Co., Inc. | Beta-secretase substrates and uses thereof |
-
2001
- 2001-07-19 IL IL15394301A patent/IL153943A0/xx not_active IP Right Cessation
- 2001-07-19 US US09/908,943 patent/US7205120B2/en not_active Expired - Fee Related
- 2001-07-19 JP JP2002512206A patent/JP2004504018A/ja not_active Withdrawn
- 2001-07-19 CA CA002410898A patent/CA2410898A1/en not_active Abandoned
- 2001-07-19 EP EP01955899A patent/EP1301604B1/en not_active Expired - Lifetime
- 2001-07-19 AT AT01955899T patent/ATE397077T1/de not_active IP Right Cessation
- 2001-07-19 AU AU2001277950A patent/AU2001277950A1/en not_active Abandoned
- 2001-07-19 DE DE60134230T patent/DE60134230D1/de not_active Expired - Lifetime
- 2001-07-19 TW TW090117695A patent/TWI316960B/zh not_active IP Right Cessation
- 2001-07-19 WO PCT/US2001/023035 patent/WO2002006306A2/en active Application Filing
- 2001-07-19 TW TW095116459A patent/TW200628612A/zh unknown
-
2003
- 2003-01-14 IS IS6678A patent/IS6678A/is unknown
-
2004
- 2004-03-16 US US10/801,486 patent/US20040254342A1/en not_active Abandoned
- 2004-03-16 US US10/801,938 patent/US20040253706A1/en not_active Abandoned
- 2004-03-16 US US10/801,493 patent/US20050096457A1/en not_active Abandoned
- 2004-03-16 US US10/801,509 patent/US7888291B2/en not_active Expired - Fee Related
- 2004-03-16 US US10/801,487 patent/US7803739B2/en not_active Expired - Fee Related
-
2007
- 2007-03-01 US US11/713,091 patent/US20080299596A1/en not_active Abandoned
- 2007-05-24 US US11/753,331 patent/US20080090260A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1301604A2 (en) | 2003-04-16 |
US20040254342A1 (en) | 2004-12-16 |
US20030017991A1 (en) | 2003-01-23 |
US20080299596A1 (en) | 2008-12-04 |
ATE397077T1 (de) | 2008-06-15 |
US7803739B2 (en) | 2010-09-28 |
US7205120B2 (en) | 2007-04-17 |
US20040253706A1 (en) | 2004-12-16 |
US7888291B2 (en) | 2011-02-15 |
US20080090260A1 (en) | 2008-04-17 |
US20050096457A1 (en) | 2005-05-05 |
WO2002006306A2 (en) | 2002-01-24 |
EP1301604B1 (en) | 2008-05-28 |
TW200628612A (en) | 2006-08-16 |
DE60134230D1 (de) | 2008-07-10 |
US20040241792A1 (en) | 2004-12-02 |
JP2004504018A (ja) | 2004-02-12 |
IS6678A (is) | 2003-01-14 |
WO2002006306A3 (en) | 2002-07-25 |
US20040254341A1 (en) | 2004-12-16 |
CA2410898A1 (en) | 2002-01-24 |
TWI316960B (en) | 2009-11-11 |
AU2001277950A1 (en) | 2002-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200628612A (en) | Substrates and assays for β-secretase activity | |
WO1996017924A3 (en) | Novel hedgehog-derived polypeptides | |
ATE308550T1 (de) | Verwendungen von sulfatierten fuko- oligosacchariden zum pflanzenschutz | |
DE60037450D1 (de) | Funf-helix protein | |
IL150168A0 (en) | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon | |
DE60144145D1 (de) | Subtilisin-variante | |
YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
WO2001079461A3 (en) | Polypeptides having haloperoxidase activity | |
WO2002009641A3 (en) | Promyostatin peptides and methods of using same | |
WO2003035861A3 (en) | Thrombin-cleavable chimeric proteins | |
WO2003106619A3 (en) | MULTIFUNCTIONAL POLYPEPTIDES | |
HK1025511A1 (en) | Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors | |
RS49517B (sr) | PEPTID p277-ANALOZI I FARMACEUTSKI PREPARATI KOJI GA SADRZE | |
WO2000037487A8 (de) | INHIBITOREN DES INTEGRINS αvβ¿6? | |
WO2003099848A3 (en) | Method for universal enzymatic production of bioactive peptides | |
DE69938130D1 (de) | Neue peptide | |
AU5690400A (en) | Novel compounds | |
WO2004094478A3 (en) | Cleavage of fusion proteins using granzyme b protease | |
IL193310A0 (en) | Antibody directed against a polypeptide that interacts with parkin and pharmaceutical compositions comprising the same | |
WO2000068416A3 (de) | Methoden zur auffindung von proteasen, die spezifisch membrangebundene substrate spalten | |
ATE374824T1 (de) | Lösliche notch basierte substrate für gamma secretase, methoden, zusammensetzungen und verwendungen davon | |
MXPA02012030A (es) | Sustratos peptidicos de metalorpoteasas y metodos. | |
EP1474509A4 (en) | AGGRECANASE 1 AND 2 PEPTIDE SUBSTRATES AND METHOD | |
CA2285700A1 (en) | Renin-active substance | |
WO2003099847A3 (en) | Method for enzymatic production of glp-1 (7-36) amide peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9K | Patent not in force due to non-payment of renewal fees |